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Abstract 
Periodontitis is an inflammatory disease that often leads to destruction of 
alveolar bone. Multiple species of bacteria in subgingival plaque are 
associated with bone destruction i  periodon tis. In this kind of bone 
destruction, the osteoclast is known to play a key role. To determine the 
mediators which are involved in osteoclastogenesis by periodontopa h gen , 
we studied the effect of three periodontopathogens, Porphyromonas 
gingivalis, Treponema denticola, and Treponema socranskii o  
osteoclastogenesis in coculture system of mouse calvaria derived 
osteoblastic cells and bone marrow cells. The expression of interleukin (IL)-
1β, tumor necrosis factor (TNF)-α, receptor activator of NF-κB ligand 
(RANKL) and prostaglandin E2 (PGE2) in mouse calvaria cells was 
determined by reverse transcriptase-polymerase chain reaction (RT-PCR) 
or immunoassay. Sonicates of three bacteria induced osteoclast formation in 
coculture systems and the mRNA expression of IL-1β, TNF-α, and RANKL
in osteoblastic cells.  The production of PGE2 was increased by three 
bacteria sonicates. Addition of osteoprotegerin (OPG), which is an inhibi or 
of RANKL, in the cocultures resulted in th  complete suppression of the 
induction of the osteoclast formation. Anti-IL-1β antibody (Ab), anti-TNF-α 
Ab and indomethacin, which is an inhibitor of PGE2, partially nhibited the 
induction of the osteoclast formation by each bacteria. In addition, 
indomethacin, anti-IL-1β Ab, or anti-TNF-α Ab decreased RANKL 
expression of osteoblastic cells treated with bacterial sonicates of P.
gingivalis, T. denticola, and T. socranskii. These findings suggest that 
increased RANKL expression of osteoblastic cells may play an important 
role in the osteoclast formation induced by P. gingivalis, T. denticola, and T. 
socranskii and that PGE2, IL-1β, and TNF-α are mediators for the induction 
of RANKL expression by these bacteria.  
Key Words: Porphyromonas gingivalis, Treponema denticola, Treponema 
socranskii. osteoclast, interleukin-1β, umor necrosis factor-α, recep  
activator of NF-κB ligand,  prostaglandin E2 
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Introduction 
 
Since the multinucleated osteoclast plays a crucial role in bone resorption, the 
research on the osteoclast formation h  been taken an important place in 
bone biology. Osteoclast is derived from colony forming unit–macrophage 
(CFU-M) through multiple steps including the expression of tartrate resistant 
acid phosphatase (TRAP), fusion of cells, and the formation of clear zone and 
ruffled border. Osteoclast differentiation requires for the osteoblasts or b ne 
marrow stromal cells.1,2 One of the osteoclastogenesis factors expressed by 
osteoblasts or bone marrow stromal cells is receptor activator of nuc ear 
factor kB ligand (RANKL, also known as osteoclast differentiation factor). 
RANKL plays an essential role on the osteoclast differentiation. T is factor 
interacts with the receptor called RANK on osteoclast surface or on its 
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precursor for differentiation or activation of osteoclast.1,3,4,  There re 
multiple factors that lead to bone destruction  and it has been suggested that 
these multiple factors increase RANKL expression of osteoblasts or stromal 
cells. RANKL expression was  up-regulated, when the osteoblasts or stromal 
cells were stimulated by parathyroid hormon (PTH), 1α,25-dihydroxyvitamin 
D 3 (1α,25(OH)2D 3), prostaglandin E2 (PGE 2), interleukin-1 (IL-1), and tumor 
necrosis factor (TNF).5,6,7,8  However, TNF-α treatment of RANK knockout 
mice induced TRAP-positive-cells at the site of injection.9 This re ult
suggests that the RANKL-RANK interaction is not the only way to induce the 
osteoclast differentiation.  
Alveolar bone resorption followed by loss of teeth is clinically the most 
important issue in periodontitis. Bacteria harboured in periodontal pockets 
play a major role in bone destruction. As periodontitis progresses, the 
microbial flora of dental plaque has changes on its dominant bacteria and 
anaerobic gram negative bacteria establish late in the development of dental 
plaque. Porphyromonas gingivalis has been considered as one of the most 
important pathogenic microorganism associated with periodontal disease.10,11 
Some previous studies showed that cell wall components of P. gingivalis, such 
as fimbriae, lipopolysaccharide (LPS), and other surface-associated m terials 
were potent stimulator of osteoclast differentiation and bone resorption via 
IL-1, IL-6, TNF, and PGE2. 12,13,14  
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Spirochetes can represent up to 50% of the de ectable bacteria in subgingival 
plaque from patients with chronic adult periodontitis.15 T eponem  denticola, 
which is one of the oral spirochetes, has been most intensively s udied in 
terms of its virulence factors. This bacterium is able to destruct host tissue by 
its proteolytic activity and cytotoxicity.16,17 Expecially, LPS-like substance 
existing in the outer membrane of T. denticolancreased calcium released 
from calvaria bone.18  Also, T. denticola increased the number of osteoclast 
formation and up-regulation of the RANKL expression via PGE2-dependant 
machanism was involved this process.19 Thes  findings suggest that T. 
denticola may contribute to the alveolar bone resorption. Treponema 
socranskii, wh ch is another specie of treponeme, predominates in deep 
periodontal pocket.  T socranskii  has a protease activity20, viscosity-
dependant locomotion, laminin21 and collagen binding protein22. However, he 
relationship between T. socranskii and bone destruction is little known.  
Periodontitis is a polymicrobial infection. Therefore it is importa t to clarify 
whether there is a common pathway of bone destruction induced by 
periodontopathogens. There were two groups tried to compare the machanism 
of bone resorption caused by each periotontopathic bacteria. LPS from P.
gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans 
promoted osteoclastic cell formation in bone marrow cell cultures.23 Bone 
resorption in mouse calvaria was caused by three periodontal pathog ns, P. 
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gingivalis, C mpylobacter rectus, and Fusobacterium nucleatum, and it was 
mediated in part by prostaglandin.24 Although these results suggest that 
periodontopathic bacteria may stimulate bone destruction in similar mechanism, 
the more precise mechanism such as involvement of cytokines and RANKL has 
not been yet discovered.  
In clinical study, coinfection of P. gingivalis and T. de ticola was frequently 
observed in periodontitis.25 P. gi g valis and T. denticola coaggregated 
strongly26 and showed a nutritional relationship.27 Recently, it was reported 
that P. gingivalis, T. denticola, and T. socranskii were associated with severity 
of periodontal tissue destruction.28 Therefore, to identify whether there is a 
common pathway of bone destruction by periodontopathogens, we compared 
the mechanisms of the osteoclastogenesis induced by these bacterial 
sonicates P. gingivalis, T. denticola, and T. socranskii. We found that three 
periodontopathic bacteria induce osteoclast formation via RANKL-dependent 
pathway and the RANKL expression is mediated by PGE2, IL-1β, and TNF-α.         
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Materials and Method 
 
Materials 
 
The mice (ICR strain) were obtained from Bio Korea Co. (Seoul, Korea). The 
α-minimum essential medium (α-MEM) and heat-inactivated fetal bovine 
serum (FBS) were purchased from GIBCO BRL (Grand Island, NY). 
Indomethacin and tartrate-resistant acid phosphatase (TRAP; a marker of 
osteoclast ) staining kit were obtained from Sigma (St. Louis, MO ). OPG, anti-
IL-1β antibody (IL-1β Ab), and anti-TNF-α Ab were purchased  from  R&D 
systems (Minneapolis, USA) 
 
Method 
 
Preparation of bacteria sonicates.  P. g ngivalis (ATCC 33277) were cultured 
anaerobically in barin-heart infusion medium containing hemin (5 µg/ml) and 
menadione (0.5 µg/ml) for 2 days. T. denticola (ATCC 33521) and  T. 
socrnaskii (ATCC 33536) were cultured anaerobically in an OMIZ-PAT broth 
for 3-5 days, as described previously.46  Bacterial cells were harvested by 
centrifuging at 5,000 x g for 10 min at 4℃. The cells were then washed 3 
times with phosphate buffered saline (PBS). Th  bacterial cells w e then 
disrupted for 5 min using an ultrasonic processor (Sonic Dismembrator, Fisher 
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Scientific, Pittsburgh, PA) at an o tput power of 8 watts with 20 sec intervals. 
The cell debris was removed after centrifuging at 15,000 × g for 5 m n at 4℃ 
and the supernatant was collected. The protein concentrations were 
determined using a Coomassie brilliant protein assay reagent (Pierce, 
Rockford, IL). 
 
Preparation of primary calvaria and bone marrow cells. The osteoblastic cells 
were isolated from the calvariae of 1-2-d y-old ICR mice as prevously
described.5 The calvariae were digested in 10 ㎖ of α-MEM containing 0.2% 
collagenase (Wako Pure Chemicals, Osaka, Japan) and 0.1% dispase (GIBCO 
BRL, Grand Island, NY) for 20 min at 37℃ with vigorous shaking, and then 
centrifuged at 1,500 ×g for 5 min. The first supernatant was discarded and
another 10 ㎖ of the collagenase/dispase enzyme solution was added and 
incubated for 20 min. The digestion was repeated 4 times and thecells 
isolated by the last three digestions were combined as an osteoblastic cells. 
They were cultured in α-MEM containing 10% FBS, antibiotics solution (100 
U/㎖ of penicillin, 100 µg/㎖ of streptomycin, 25 µg/㎖ of amphotericin B) and 
used for the coculture system. The bone marrow cells were collected fro  5-
8-week-old mice. The ends of the tibiae and femurs were removed and the 
marrow cavity was flushed by slowly injecting media at one end using a 25 
gauge needle. The marrow cells were washed and used for the coculture. 
7  
 
Osteoclast formation assay. The isolated calvaria cells were seeded at a 
concentration of 106 cells in a 10 cm culture dish and grown to confluence. 
The cells were then detached from th  culture dishes by trypsin-EDTA 
(GIBCO BRL, Grand Island, NY). Subsequently, the cells (1x104 cel s/well) 
were cocultured with the bone marrow cells (1 x105 c lls/well) in α-MEM
containing 10% FBS in 48 well plates (Corning Inc., NY). The culture volume 
was made up to 200 ㎕ per well with α-MEM medium con aining 10% FBS. 
The bacteria sonicates was added to the coculture with or without OPG, 
indomethacin, anti-IL-1β Ab, or anti-TNF-α Ab after exchanging the medium 
on day 3. The coculture was then maintained for an additional 4 days. 
Osteoclast differentiation was monitored using a TRAP staining kit according 
to the manufacturer’s instruction. The TRAP-positive multinucleated cells 
showing more than 3 nuclei per well were counted as an osteoclast. 
 
Osteoblastic cell cultures.  Osteoblastic cells isolated from mouse calvariae 
were seeded in 48-well plate at a density of  1.3×104  cells/dish n ml α-MEM
containing 10% FBS. When the cells grew to 80% confluence, the medium was 
exchanged with α-MEM containing 10%FBS and cells were exposed to 
bacteria sonicates alone or in combination with anti-IL-1β Ab, anti-TNF-α Ab 
for indicated times. To determine  mRNA expression of  RANKL and 
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cytokines, mRNA was isolated from the cultured osteoblastic cells by TRIzol 
reagent according to the manufacturer’s protocol (Life Technologies, Inc., 
Grand Island, NY). The concentration of PGE2  and RANKL in culture media 
was measured by enzyme immunoassay. 
 
Reverse transcriptase-polymerase chain reaction (RT-PCR). RANKL, IL-1β, 
and TNF-α mRNA expression was determined by RT-PCR. The total RNA (1
㎍) from the non-treated and treat d osteoblastic cells was used as a template 
for cDNA synthesis in a 20 ㎕ of reaction volume using an RT kit (CLONTECH, 
Palo Alto, CA) according to the manufacturer’s instructions. The RNA (1 µg) 
and oligo(dT)18 primer (1 mM) were denatured at 70℃ for 5 min and incubated 
1-2 min on ice. The denatured RNA and oligo(dT)18 primers were added to the 
reaction mixture (1 unit/㎕ MMLV reverse transcriptase; 1× r action buffer; 
500 μM of each dATP, dCTP, dGTP and dTTP; 20 units of recombinant RNase 
inhibitor), and incubated at 42℃ for 60 min followed by 94℃ for 5 min. 
The cDNA (4 ㎕) was amplified by PCR in a 50 ㎕ reaction volume containing 
the 1 x PCR reaction buffer, 200 μM dNTPs, 200 pM of the forward and 
reverse primers, and 0.5 units of Taq DNA polymerase (Amersham Pharmacia 
Biotech., Little Chalfont, Buckinghamshire, UK) in a DNA thermal cycler 
(Biometra, Goettingen, Germany). The amplification reaction was performed 
for 35 cycles and primer sequences and annealing temperatures are prese t d 
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in Table 1. The PCR products were separated by electrophoresis on a 1.5% 
agarose gel and visualized by ethid um bromi e stain ng. The relat ve int nsity 
of the gel bands was measured using an image-analyzing program (TINA 2.0e, 
Neuro-Image analysis Centre, Oxford, UK). In order to exclude DNA 
contamination in the isolated RNA, the RNA was subjected to PCR without
cDNA synthesis. In all preparatios, no band was detected after PCR. 
 
 
Table 1. Sequences of primers for RANKL, IL-1β, TNF-α, and β-actin 
 
 
Molecule 
 
Direction 
 
Primer sequence 
Annealing 
temp(°C) 
Product
size 
(bp) 
RANKL Forward 
Reverse 
5′-ATCAGAAGACAGCACTCACT-3′ 
5′-ATCTAGGACATCCATGCTAATGTTC-3′ 
45.3 
 
750 
TNF-α Forward 
Reverse 
5′-TTCTGTCTACTGAACTTCGGGGTGATCGGTCC-3′ 
5′-GTATGAGATAGCAAATCGGCTGACGGTGTGGG-3′ 
60 354 
IL-1β Forward 
Reverse 
5′-ATGGCAACTGTTCCTGAACTCAAGT-3′ 
5′-CAGGACAGGTATAGATTCTTTCCTTT-3′ 
50 563 
β-actin Forward 
Reverse 
5′-GGACTCCTATGGTGGGTGACGAGG-3′ 
5′-GGGAGAGCATAGCCCTCGTAGAT-3′ 
58 366 
 
 
Immunoassay for RANKL and PGE2 The level of PGE2 and RANKL in culture 
media of  osteoblasts were determined  using a  PGE2 nzy e immunoassay 
kit (Amersham Bioscience, Uppsala, Sweden) and  RANKL enzyme 
immunoassay kit (R&D systems, Minneapolis, USA) according to the 
10  
manufacture’s instruction.   
 
Statistical analyses. The statistical differences were determined by Mann-
Whitney U test. A p value < 0.05 was considered significant. 
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Results   
 
Osteoclast formation induced by sonicates of periodontopathogens. 
The osteoclast forming activity of P. gingival s, T. denticola, and T. socranskii  
was determined in coculture system of mouse calvaria-derived oste blastic
cells and bone marrow cells (Fig. 1). TRAP-positive multinucleated cells 
which had 3 or more nuclei were defined  as osteoclasts  and counted. In 
untreated cultures, the number of TRAP-positive multinucleated cells w re 
less than 50. Addition of sonicates from P. gingivalis, T. denticola, or
socranskii increased the number of TRAP-positive multinucleated cells. 
Maximum effect of P. gingivalissonicates was observed at 0.01-0.1 µg/ml.T
denticola sonicates increased the number of TRAP-positive cells in a dose 
dependent manner in the range of 0.1-1 µg/ml, and the number of TRAP-
positive cells was decreased at 10 µg/ml when compared with 1 µg/ml 
sonicates-treated cells. In cells treated with T. soncranskii son cates,  
maxiumum effect was maintained at the range of 0.1-10 µg/ml.  
Effect of bacteria sonicates on expression of RANKL, cytokines, and PGE2 
To elucidate the effect of periodontopathogens on expression of RANKL, IL-
1β, and TNF-α which are involved in osteoclastogenensis, The mRNA level of 
RANKL, IL-1β, and TNF-α was observed in osteoblastic cells 
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Figure 1. Osteoclastogenesis induced by sonicates of Porphyromonas gingivalis, 
Treponema denticola, and Treponema socranskii. Mou e bone marrow and calvarial 
cells were cocultured to confluence and treated with sonicates of P. gi givalis (0.01-
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0.1 µg/ml), T. denticola (0.1-10µg/ml) or T. socranskii (0.1-10 µg/ml) for additional 4 
days. The cells were then stained for TRAP. The TRAP-positive multinucleated cells 
containing more than three nuclei were counted as osteoclasts. The data are the means 
± standard errors for four cultures. * P <0.05 for a comparison with the results for the 
nontreated cultures.   
 
 
treated with sonicates of P. g ngivalis (0.1µg/ml), T. denticola (1 µg/ml) or T. 
socranskii (1µg/ml) (Fig. 2). Untreated osteoblastic cells expressed low level 
of RANKL, IL-1β, and TNF-α mRNA. When osteoblastic cells were treated 
with P. gingivalis sonicates, the mRNA level of RANKL, IL-1β, and TNF-α 
was increased. Sonicates of T. denticola and T. socranskii also increased the 
expression of RANKL, IL-1β, and TNF-α mRNA. Immunoassay for PGE2 
revealed a significant increase in the amount of PGE2 in the culture 
supernatants  of osteoblastic cells reated with sonicates of eah bacteria (Fig 
3). Indomethacin, which is inhibitor of PGE2 synthesis, completely suppressed  
PGE 2 production of treated cells.  
Involvement of RANKL, PGE2, IL-1β, and TNF-α in osteoclastogenesis  
induced by three periodontopathogens.  
To confirm the involvement of RANKL, PGE2, IL-1β, and TNF-α in 
periodontopathogen–inudced osteoclastogenesis, cocultures was treated with 
sonicates of P. gingivalis(0.1 µg/ml), T denticola (1 µg/ml) or T. socranskii (1 
µg/ml) in the presence or absence of OPG, indomethacin, anti 
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Figure 2. mRNA expression of RANKL, IL-1β, and TNF-α in osteoblastic cells treated 
with sonicates of Porphyromonas gingivalis, Treponema denticola, or T eponema 
socranskii. A, Osteoblastic cells isolated form mouse c lvaria were treated with  
sonicates of P. gingivalis(Pg, 0.1 µg/ml), T. denticola (Td, 1 µg/ml) or T. socranskii 
(Ts, 1 µg/ml) for 8 h. The RNA was isolated from the treated cells. The mRNA level of 
IL-1β, TNF-α, and β-actin was analyzed by RT-PCR. B, Mouse calvaria–derived 
osteoblastic cells were cultured in the presence of sonicates of P. gingivalis (0.1 µg/ml), 
T. denticola (1 µg/ml) or T. socranskii (1 µg/ml) for 72 h and, then, the RNA was 
isolated from cultured cells. The mRNA level of RANKL was determined by RT-PCR.
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Figure 3. Production of PGE2 in calvaria-derived osteoblastic cells treated with 
sonicates of Porphyromonas gingivalis, Treponema denticola, and Treponema 
socranskii. Calvaria-derived osteoblastic cells were treated with sonicates of 
P. gingivalis (Pg, 0.1 µg/ml), Treponema denticola (Td, 1 µg/ml), or 
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Treponema socranskii (Ts, 1 µg/ml) for 72h in the absence or presence of 
indomethacin (1 mM). The PGE2 concentration was determined by using a 
PGE 2 enzyme immunoassay kit. The data are the means ± standard errors for 
three cultures. * P <0.05 for a comparison with the results for the nontreated 
cells. ** P <0.05 for a comparison with the results for sonicates treated cell  
 
 
IL-1β Ab or anti-TNF-α Ab for 4 days. OPG is a decoy receptor for RANKL 
and bind to RANKL to inhibit its activity.4  Indomethacin s an inhibitor of 
PGE 2 synthesis. OPG, indomethacin, anti-IL-1β Ab, and anti-TNF-α Ab  
decreased formation of TRAP-positive multinucleated cells when compared 
with each sonicate treated cells (Fig. 4). Addition of OPG  in cocultures
completely reduced the number of TRAP-positive cells to the level of non 
treated cells. Indomethacin,  
anti-IL-1β Ab, and anti-TNF-α Ab partially decreased the number of TRAP-
positive multinucleated cells induced by P. gingivalis, T. denticola orT. 
socranskii  sonicates. OPG, indomethacin, anti-IL-1β Ab or anti-TNF-α Ab 
did not induce the formation of TRAP-positive multinucleated cells.  
Involvement of PGE2, IL-1β, and TNF-α on expression of RANKL induced by 
periodontopathogens.  
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Figure 4. The effect of OPG, indomethacin, anti-IL-1β Ab, and anti-TNF-α Ab on 
osteoclastogenesis induced by sonicates of Porphyromonas gingivalis, Tr ponema 
denticola, or T eponema socranskii. Cocultures were treated with sonicates of P. 
gingivalis (Pg, 0.1 µg/ml), T. denticola (Td, 1 µg/ml), and T. socranskii (Ts, 1 µg/ml) in 
the absence or presence of OPG (100 ng/ml), indometahcin (1 mM),anti-IL-1β Ab (20 
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µg/ml), or anti-TNF-α Ab (2 µg/ml) for 4 days. The cells were then stained for TRAP 
to count the number of osteoclasts. The data are the means ± andard errors for three 
cultures. * P <0.05 for a comparison with the results for the nontreated cells. ** P
<0.05 for a comparison with the results for the sonicates treated ce l
 
To determine the mediators which stimulate RANKL expression of 
osteoblastic cells treated with P. gingivalis, T. denticola or T. socranskii, 
indomethacin, anti-IL-1β Ab or anti-TNF-α Ab was added to culture of 
osteoblastic cells in combination with sonicates of  P. gingivalis (0.1 µg/ml) T. 
denticola (1 µg/ml), or T. socranskii (1 µg/ml) and, after 3 days culture, 
RANKL production was determined byimmunoassay (Fig. 5). Addition of these 
inhibitors resulted in a reduction of RANKL production stimulated by sonic s 
of P. gingivalis, T. denticola, or T. socranskii. Inhibitory effect of indomethac n
was stronger than that of anti-IL-1β Ab and anti-TNF-α Ab. 
Indomethacin ,anti-IL-1β Ab or anti-TNF-α Ab did not affect on RANKL 
expression of cells. inhibitors resulted in a reduction of RANKL production 
stimulated by sonicates of P. gingivalis, T. denticola, or T. socranskii. 
Inhibitory effect of indomethacin was stronger than that of anti-IL-1β Ab and 
anti-TNF-α Ab. Indomethacin ,anti-IL-1β Ab or anti-TNF-α Ab did not affect 
on RANKL expression of cells. 
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Figure 5. The effect of indomethacin, anti-IL-1β Ab, and anti-TNF-α Ab on RANKL 
expression of osteoblastic cells by sonicates of of Porphyromonas gingivalis, 
Treponema denticola, and Treponema socranskii. Osteoblastic cells isolated form 
mouse calvaria were treated with sonicates of P. gingivalis (Pg, 0.1 µg/ml), T. denticola 
(Td, 1 µg/ml) or T. socranskii (T , 1 µg/ml) in the absence or presence of indomethacin 
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(1 mM), anti-IL-1β Ab (20 µg/ml) or anti-TNF-α Ab (2µg/ml) for 72h. The 
concentration of RANKL was determined by RANKL ELISA kit. The data are the means 
± standard errors for three cultures. * P <0.05 for a comparison with the results for the 
nontreated cells. ** P <0.05 for a comparison with the results for bacteria sonicates 
treated cells 
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Discussion 
 
The results of the present study show that osteoclastogenesis is stimulated by 
P. gingivalis, T. denticola, and T. socranskii. We analyzed the ability of three 
periodontopathogens, P. gingivalis, T. denticola,and T socranskii, to form 
osteoclast. All bacteria enhanced osteoclastogenesis in cocultur sy m. Both 
of T. denticola and T. socrankii showed maximum effect on osteoclastogensis 
at 1 µg/ml, but P. gingivalis sonicates showed cytotoxic effect on cells at 1 
µg/ml. One of the potentially significant virulence characteristics of P. 
gingivalis is that this bacterium produces a large number of hydrolytic, 
proteolytic and lipolytic enzymes compared with other bacteria and many of 
these enzyme are either exposed at outer membrane, within the periplasmic 
space or in outer membrane vesicles.29 This suggest that cytotoxic effect at 1 
µg/ml ofP. gingivalis sonicates might be due to various enzymes which are 
contained in bacterial sonicates. 
Osteoclastogenesis is controlled by various factors including cytokine, PGE2
and hormones. RANKL, produced by osteoblasts, is an essential fact r that
plays a key role in osteoclastogenesis.1 Also, it has been reported that 
prostaglandins30,31,32, TNF-α33, IL-1β34 increase bone resorption and 
osteoclast formation. It has been reported that P. gingivalis can induce the up-
regulation of IL-1, TNF, and PGE2.35 T. de ticola also can induce the up-
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regulation of IL-1 and TNF-α.36 In present study, sonicates of three bacteria 
stimulated expression of RANKL, PGE2, IL-1β, and TNF-α in calvaria derived 
osteobasltic cells. In addition, the stimulated osteoclastogenesis wa  
significantly inhibited by treatment with antibodies against IL-1β, and TNF-α 
and inhibitors against RANKL and PGE2. This means that the bacteria 
sonicate-stimulated osteoclastogenesis in our assay was mediated by 
endogenous RANKL, PGE2, IL-1β, and TNF-α activity. Interestingly, the 
bacteria sonicates-induced osteoclastogenesis was strongly suppres ed to 
basal level by OPG, which is RANKL inhibitor, while partially suppressed by 
indomethacin, antibody of IL-1β and antibody of TNF-α. These results 
suggested that osteoclastogenesis induced by P. gingivalis, T. denticola, and T. 
socranskii is mainly regulated via RANKL.  
RANKL is produced from osteoblasts and its production is controlle by 
various bone resorption-inducing factors.  IL-1 increase RANKL production
in stromal /osteoblastic cells.37 Like IL-1, TNF–stimulated induction of 
osteoclastogenesis in bone marrow culture38 was mediated by increase in 
RANKL expression.39  PGE2 stimulate osteoclast formation in marrow 
cultures.40 Induction of RANKL has been shown to be essential for bone 
resorption via PGE2.41 Taken together with these studies and our results, the 
possibility that PGE2, IL-1β, and TNF-α may relate to RANKL expression of 
osteoblatic cells by periodontopathogens. In our study, osteoblas ic cells 
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treated with each bacterial soniates showed increased the production of PGE2 
and the mRNA expression of IL-1β and TNF- α. Inhibitors of these factors 
including indomethacin, anti IL-1β Ab, and anti TNF-α Ab reduced not only 
osteoclatogensis  but  also  RANKL production of  osteobasltic cells by 
bacteria sonicates. These  results  strongly suggest the mediation of PGE2, 
IL-1β and TNF-α in the RANKL expression stimulated by three 
periodontopathogens.  
It has been reported that P. gingivalis can contribute to bone resorption. 
Previously, it was reported that P. gingivalis sonicates enhanced the mineral 
resorption via osteogenic cells.42 Live and h at killed P. gingivalis stimulated 
bone resorption of mouse calvaria. Treatment of mice concomitantly with 
indometahcin reduced bone resorption y this bac eria, suggesting that their 
effects were mediated by prostaglandins somehow.43 This b cteria elicited 
mRNA expression of IL-1β and 6, potent bone resorbing cytokines, in vivo 
calvarial model. In murine calvaria jected with live P. gingivalis, IL-1 and 
TNF mRNA was elicited.44 LPS of P. gingivalis significantly increased the 
number of osteoclast-like cells in bone marrow culture.23 P. gingivalis LPS 
stimulated expression of IL-1β and IL-6 genes in calvarial cells and LPS-
stimulated bone resorption was markedly inhibited by antibodies against IL-1β
and IL-6.45 IL-1 was markedly expressed in the P. gingivalis fimbriae-treated 
calvarial bone cells and fimbriae stimulated bone resorption was abolished 
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significantly by antisera against IL-1.46 These repor s suggest that P. 
gingivalis induce the bone resorption via IL-1β, TNF, and PGE2. In this study, 
we found that P. gingivalis stimulated osteoclastogenesis via RANKL and 
RANKL expression was mediated by IL-1β, TNF-α, and PGE2. In addition, T. 
denticola and T. socranskii e hanced osteoclast formation via the similar 
mechanism to P. gingivalis. These suggest that three periodontopathogens 
appear to stimulate osteocalstogenesis in the same manner. It has been 
reported that IL-1 and TNF-α induce PGE2.47 Therefore, the IL-1β and TNF-
α may contribute to PGE2 induction in osteoblast by three 
periodontopathogens used in this study and further studies are required to
clarify this question.  
 
In summary, the present study provides evidence for the involvement of 
RANKL in osteoclastogenesis induced by three periodontopathogens such as P. 
gingivalis, T. denticola, and T. socranskii, and for the induction of RANKL via 
PGE 2, IL-1β, and TNF-α. It is important clinically to develop drugs that can 
prevent the alveolar bone loss associated with periodontal disease. In his 
consideration, inhibitor of PGE2, IL-1β, and TNF-α will be good therapeutic 
agent and, especially, inhibitor of RANKL such as OPG will be the most
effective on prevention of bone destruction by periodontopathogens 
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국문 요약 
Porphyromonas gingivalis, Treponema denticola, Treponema 
socranskii에 의하여 유도된 RANKL 의존 파골세포 형성에 있어서  
PGE 2, IL-1β, TNF-α의 매개 
 
    김      기      환 
       연세대학교 대학원 치의학과 
 
     지도교수 유윤정 
 
치주염은 치조골의 흡수를 동반하는 염증성 질환으로 치은연하 치태내의 여러 종
류의 미생물이 치조골 흡수에 영향을 준다. 이러한 여러 종류의 치주병인체로 인
하여 발생하는 여러 파골세포형성 인자 중에서 공통된 인자를 찾기 위해, 마우스 
두개골 기원의 조골세포와 골수 세포의 혼합배양에서 세 종류의 치주병인체, 즉, 
Porphyromonas gingivalis, Treponema denticola 및 Treponema socranskii에 
의한 파골세포형성 기전을 관찰하였다. 조골세포의 interleukin (IL)-1β, tumor 
necrosis factor (TNF)-α, eceptor activator of NF-κB ligand (RANKL) 및 
prostaglandin E2 (PGE2)의 발현은 reverse transcriptase polymerase chain 
reaction (RT-PCR) 및 면역분석법을 통하여 관찰하였다. 세 종의 세균 분쇄액은 
혼합배양에서 파골세포형성을 촉진하였고, 조골세포의 RANKL, IL-1β 및 TNF-α
의 mRNA 발현 그리고 PGE2 의 생성을 증가시켰다. RANKL의 억제 인자인 
osteopotegerin (OPG)는 각 세균 분쇄액에 의한 파골세포형성을 완전히 억제하였
30  
다. 또한 PGE2 형성 억제 인자인 indomethacin, anti-IL-1β antibody (Ab), 및 
anti-TNF-α Ab가 더해졌을 때 각각의 미세균 분쇄액의 파골세포 형성능이 저하
되었다. 또한, indomethacin, anti-IL-1β Ab, 또는 anti-TNF-α Ab는 P. 
gingivalis, T. denticola, 및 T. socranskii 분쇄액 으로 처리된 조골 세포내에서 
RANKL 발현을 저하시켰다. 이는 P. gingivalis, T. denticola, 및 T. socranskii가 
조골세포의 RANKL의 발현을 증가시켜 파골세포 형성을 촉진하며, 이러한 세 종
의  미생물에 의한 RANKL 발현에 IL-1β, TNF-α 및 PGE2 가 중간 매개체로 작
용한다는 것을 보여주고 있다.  
 
